药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Choline salicylate
The risk or severity of adverse effects can be increased when Palbociclib is combined with Choline salicylate.
Tasosartan
Nafamostat
The risk or severity of adverse effects can be increased when Palbociclib is combined with Nafamostat.
Tasosartan
Dexchlorpheniramine maleate
The risk or severity of adverse effects can be increased when Palbociclib is combined with Dexchlorpheniramine maleate.
Tasosartan
Cyclopenthiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Palbociclib.
Tasosartan
Mebutizide
The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Palbociclib.
Tasosartan
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Palbociclib.
Tasosartan
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Palbociclib.
Tasosartan
Clorindione
The risk or severity of bleeding can be increased when Clorindione is combined with Palbociclib.
Tasosartan
Fluindione
The risk or severity of bleeding can be increased when Fluindione is combined with Palbociclib.
Tasosartan
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Palbociclib.
Tasosartan
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Palbociclib.
Tasosartan
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Palbociclib.
Tasosartan
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Palbociclib.
Tasosartan
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Palbociclib.
Tasosartan
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Palbociclib.
Tasosartan
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Palbociclib.
Tasosartan
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Palbociclib.
Tasosartan
Tioclomarol
The risk or severity of bleeding can be increased when Tioclomarol is combined with Palbociclib.
Tasosartan
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Palbociclib.
Tasosartan
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Palbociclib.